Merida Biosciences has emerged from Third Rock Ventures with $121 million in first-round financing for a pipeline of drugs for autoimmune diseases, headed by a Graves' disease candidate. The Cambridge ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
RECALL ALERT: There are 2 recalls on this vehicle. Learn More. There are 2 recalls on this vehicle. Learn More. RECALL ALERT: There are 2 recalls on this vehicle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback